First Bank & Trust lowered its stake in shares of Cooper Companies Inc (NYSE:COO) by 31.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 86 shares of the medical device company’s stock after selling 40 shares during the period. First Bank & Trust’s holdings in Cooper Companies were worth $25,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently added to or reduced their stakes in the company. Essex Savings Bank bought a new stake in Cooper Companies in the fourth quarter worth $25,000. Certified Advisory Corp bought a new stake in Cooper Companies in the fourth quarter worth $25,000. Executive Wealth Management LLC bought a new stake in Cooper Companies in the fourth quarter worth $34,000. Financial Gravity Companies Inc. bought a new stake in Cooper Companies in the fourth quarter worth $46,000. Finally, Rehmann Capital Advisory Group increased its position in Cooper Companies by 24.3% in the fourth quarter. Rehmann Capital Advisory Group now owns 220 shares of the medical device company’s stock worth $56,000 after purchasing an additional 43 shares during the last quarter.
Several equities research analysts recently weighed in on the stock. Zacks Investment Research cut shares of Cooper Companies from a “hold” rating to a “sell” rating in a research report on Tuesday, February 5th. Stephens boosted their price target on shares of Cooper Companies from $305.00 to $320.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 6th. Wells Fargo & Co boosted their price target on shares of Cooper Companies from $305.00 to $325.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 6th. Raymond James boosted their price target on shares of Cooper Companies from $300.00 to $325.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 6th. Finally, Piper Jaffray Companies restated an “overweight” rating and issued a $325.00 price target on shares of Cooper Companies in a research report on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $307.90.
NYSE COO opened at $288.98 on Wednesday. The company has a quick ratio of 0.75, a current ratio of 1.27 and a debt-to-equity ratio of 0.49. The firm has a market cap of $14.60 billion, a price-to-earnings ratio of 25.13, a PEG ratio of 2.29 and a beta of 0.88. Cooper Companies Inc has a 52 week low of $220.90 and a 52 week high of $302.36.
Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Tuesday, March 5th. The medical device company reported $2.88 EPS for the quarter, topping the consensus estimate of $2.50 by $0.38. The company had revenue of $628.10 million during the quarter, compared to analyst estimates of $618.50 million. Cooper Companies had a net margin of 14.22% and a return on equity of 17.56%. Analysts predict that Cooper Companies Inc will post 12.01 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece was originally published by BBNS and is the property of of BBNS. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://baseballnewssource.com/2019/04/17/cooper-companies-inc-coo-stake-lessened-by-first-bank-trust/3359315.html.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Further Reading: What are benefits of a growth and income fund?
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.